NCT03744026View on ClinicalTrials.gov

Safety and Efficacy of Transient Opening of the Blood-brain Barrier (BBB) With the SonoCloud-9

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

February 18, 2019

Primary Completion Date

June 23, 2021

Study Completion Date

June 30, 2022

Conditions
Glioblastoma, Adult
Interventions
DEVICE

SonoCloud-9

Escalating numbers of ultrasound beams at constant acoustic pressure

DRUG

Carboplatin

Dose of carboplatin infusion is AUC4-6

Trial Locations (6)

60611

Northwestern University, Chicago

77030

MD Anderson Cancer Center, Houston

Unknown

CHU, Angers

Hôpital Neurologique Pierre Wertheimer, Bron

Hôpital de La Timone, Marseille

Hôpital de la Pitié-Salpêtrière, Paris

Sponsors

Lead Sponsor

CarThera
All Listed Sponsors
lead

CarThera

INDUSTRY

NCT03744026 - Safety and Efficacy of Transient Opening of the Blood-brain Barrier (BBB) With the SonoCloud-9 | Biotech Hunter | Biotech Hunter